Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.

Van Hout MC, Benschop A, Bujalski M, Dąbrowska K, Demetrovics Z, Felvinczi K, Hearne E, Henriques S, Kaló Z, Kamphausen G, Korf D, Silva JP, Wieczorek Ł, Werse B.

Int J Ment Health Addict. 2018;16(2):480-495. doi: 10.1007/s11469-017-9824-1. Epub 2017 Dec 7.

2.

Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.

Chenine AL, Merbah M, Wieczorek L, Molnar S, Mann B, Lee J, OʼSullivan AM, Bose M, Sanders-Buell E, Kijak GH, Herrera C, McLinden R, OʼConnell RJ, Michael NL, Robb ML, Kim JH, Polonis VR, Tovanabutra S.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):348-355. doi: 10.1097/QAI.0000000000001675.

3.

The enduring impact of neurulation stage alcohol exposure: A combined behavioral and structural neuroimaging study in adult male and female C57BL/6J mice.

Fish EW, Wieczorek LA, Rumple A, Suttie M, Moy SS, Hammond P, Parnell SE.

Behav Brain Res. 2018 Feb 15;338:173-184. doi: 10.1016/j.bbr.2017.10.020. Epub 2017 Oct 28.

4.

Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.

Ake JA, Schuetz A, Pegu P, Wieczorek L, Eller MA, Kibuuka H, Sawe F, Maboko L, Polonis V, Karasavva N, Weiner D, Sekiziyivu A, Kosgei J, Missanga M, Kroidl A, Mann P, Ratto-Kim S, Anne Eller L, Earl P, Moss B, Dorsey-Spitz J, Milazzo M, Laissa Ouedraogo G, Rizvi F, Yan J, Khan AS, Peel S, Sardesai NY, Michael NL, Ngauy V, Marovich M, Robb ML.

J Infect Dis. 2017 Nov 27;216(9):1080-1090. doi: 10.1093/infdis/jix456.

5.

Barriers in the access to alcohol treatment in outpatient clinics in urban and rural community.

Wieczorek Ł.

Psychiatr Pol. 2017 Feb 26;51(1):125-138. doi: 10.12740/PP/60345. Epub 2017 Feb 26. English, Polish.

6.
7.

Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.

Emmer KL, Wieczorek L, Tuyishime S, Molnar S, Polonis VR, Ertl HC.

AIDS. 2016 Oct 23;30(16):2405-2414.

8.

Acute alcohol exposure during neurulation: Behavioral and brain structural consequences in adolescent C57BL/6J mice.

Fish EW, Holloway HT, Rumple A, Baker LK, Wieczorek LA, Moy SS, Paniagua B, Parnell SE.

Behav Brain Res. 2016 Sep 15;311:70-80. doi: 10.1016/j.bbr.2016.05.004. Epub 2016 May 13.

9.

Overview: referrals for genetic evaluation from child psychiatrists.

Press KR, Wieczorek L, Hoover-Fong J, Bodurtha J, Taylor L.

Child Adolesc Psychiatry Ment Health. 2016 Mar 28;10:7. doi: 10.1186/s13034-016-0095-6. eCollection 2016.

10.

Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

O'Connell RJ, Excler JL, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Liu M, Wieczorek L, McNeil JG, El-Habib R, Michael NL, Gilliam BL, Paris R, VanCott TC, Tomaras GD, Birx DL, Robb ML, Kim JH.

J Infect Dis. 2016 Jun 15;213(12):1946-54. doi: 10.1093/infdis/jiw059. Epub 2016 Feb 11.

11.

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.

Wieczorek L, Krebs SJ, Kalyanaraman V, Whitney S, Tovanabutra S, Moscoso CG, Sanders-Buell E, Williams C, Slike B, Molnar S, Dussupt V, Alam SM, Chenine AL, Tong T, Hill EL, Liao HX, Hoelscher M, Maboko L, Zolla-Pazner S, Haynes BF, Pensiero M, McCutchan F, Malek-Salehi S, Cheng RH, Robb ML, VanCott T, Michael NL, Marovich MA, Alving CR, Matyas GR, Rao M, Polonis VR.

J Virol. 2015 Aug;89(15):7478-93. doi: 10.1128/JVI.00412-15. Epub 2015 May 13.

12.

Quantifying BTEX in aqueous solutions with potentially interfering hydrocarbons using a partially selective sensor array.

Cooper JS, Kiiveri H, Hubble LJ, Chow E, Webster MS, Müller KH, Sosa-Pintos A, Bendavid A, Raguse B, Wieczorek L.

Analyst. 2015 May 7;140(9):3233-8. doi: 10.1039/c5an00223k. Epub 2015 Mar 13.

PMID:
25768651
13.

Hypothalamic-pituitary-adrenal axis and behavioral dysfunction following early binge-like prenatal alcohol exposure in mice.

Wieczorek L, Fish EW, O'Leary-Moore SK, Parnell SE, Sulik KK.

Alcohol. 2015 May;49(3):207-17. doi: 10.1016/j.alcohol.2015.01.005. Epub 2015 Jan 26.

14.

High-throughput fabrication and screening improves gold nanoparticle chemiresistor sensor performance.

Hubble LJ, Cooper JS, Sosa-Pintos A, Kiiveri H, Chow E, Webster MS, Wieczorek L, Raguse B.

ACS Comb Sci. 2015 Feb 9;17(2):120-9. doi: 10.1021/co500129v. Epub 2015 Jan 23.

PMID:
25562398
15.

Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC Jr.

Clin Vaccine Immunol. 2014 Aug;21(8):1086-93. doi: 10.1128/CVI.00320-14. Epub 2014 May 28.

16.

What influences changes in alcoholic beverage consumption over time? Poland in the light of the European Union Amphora study.

Swiątkiewicz G, Wieczorek L, Allamani A.

Subst Use Misuse. 2014 Oct;49(12):1601-10. doi: 10.3109/10826084.2014.914376. Epub 2014 May 16.

PMID:
24832915
17.

Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system.

McLinden RJ, Labranche CC, Chenine AL, Polonis VR, Eller MA, Wieczorek L, Ochsenbauer C, Kappes JC, Perfetto S, Montefiori DC, Michael NL, Kim JH.

PLoS One. 2013 Nov 28;8(11):e77756. doi: 10.1371/journal.pone.0077756. eCollection 2013.

18.

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.

Chenine AL, Wieczorek L, Sanders-Buell E, Wesberry M, Towle T, Pillis DM, Molnar S, McLinden R, Edmonds T, Hirsch I, O'Connell R, McCutchan FE, Montefiori DC, Ochsenbauer C, Kappes JC, Kim JH, Polonis VR, Tovanabutra S.

PLoS One. 2013 Nov 29;8(11):e76104. doi: 10.1371/journal.pone.0076104. eCollection 2013.

19.

Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling.

Wieczorek L, Brown BK, Delsarto Macedo C, Wesberry-Schmierer M, Ngauy V, Rosa Borges A, Michael NL, Marovich MA, Montefiori DC, Polonis VR.

Virology. 2013 Dec;447(1-2):240-8. doi: 10.1016/j.virol.2013.09.014. Epub 2013 Oct 5.

20.

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.

Nilsson C, Godoy-Ramirez K, Hejdeman B, Bråve A, Gudmundsdotter L, Hallengärd D, Currier JR, Wieczorek L, Hasselrot K, Earl PL, Polonis VR, Marovich MA, Robb ML, Sandström E, Wahren B, Biberfeld G.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):299-311. doi: 10.1089/AID.2013.0149. Epub 2013 Nov 15.

21.

Site-specific modulation of brain glucocorticoid receptor and corticotropin-releasing hormone expression using lentiviral vectors.

Laryea G, Arnett MG, Wieczorek L, Muglia LJ.

Mol Cell Endocrinol. 2013 May 22;371(1-2):160-5. doi: 10.1016/j.mce.2012.12.005. Epub 2012 Dec 20.

22.

Designing a soluble near full-length HIV-1 gp41 trimer.

Gao G, Wieczorek L, Peachman KK, Polonis VR, Alving CR, Rao M, Rao VB.

J Biol Chem. 2013 Jan 4;288(1):234-46. doi: 10.1074/jbc.M112.424432. Epub 2012 Nov 26.

23.

Absence of Ca2+-stimulated adenylyl cyclases leads to reduced synaptic plasticity and impaired experience-dependent fear memory.

Wieczorek L, Majumdar D, Wills TA, Hu L, Winder DG, Webb DJ, Muglia LJ.

Transl Psychiatry. 2012 May 29;2:e126. doi: 10.1038/tp.2012.50.

24.

Gold nanoparticle chemiresistors operating in biological fluids.

Hubble LJ, Chow E, Cooper JS, Webster M, Müller KH, Wieczorek L, Raguse B.

Lab Chip. 2012 Sep 7;12(17):3040-8. doi: 10.1039/c2lc40575j. Epub 2012 Jul 23.

PMID:
22824995
25.

The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.

Brown BK, Wieczorek L, Kijak G, Lombardi K, Currier J, Wesberry M, Kappes JC, Ngauy V, Marovich M, Michael N, Ochsenbauer C, Montefiori DC, Polonis VR.

PLoS One. 2012;7(4):e29454. doi: 10.1371/journal.pone.0029454. Epub 2012 Apr 11.

26.

Dynamic response of gold nanoparticle chemiresistors to organic analytes in aqueous solution.

Müller KH, Chow E, Wieczorek L, Raguse B, Cooper JS, Hubble LJ.

Phys Chem Chem Phys. 2011 Oct 28;13(40):18208-16. doi: 10.1039/c1cp20242a. Epub 2011 Sep 19.

PMID:
21931887
27.

Contextual determinants of alcohol consumption changes and preventive alcohol policies: a 12-country European study in progress.

Allamani A, Voller F, Decarli A, Casotto V, Pantzer K, Anderson P, Gual A, Matrai S, Elekes Z, Eisenbach-Stangl I, Schmied G, Knibbe RA, Nordlund S, Skjælaaen Ø, Olsson B, Cisneros Örnberg J, Österberg E, Karlsson T, Plant M, Plant M, Miller P, Coghill N, Swiatkiewicz G, Wieczorek Ł, Annaheim B, Gmel G.

Subst Use Misuse. 2011;46(10):1288-303. doi: 10.3109/10826084.2011.572942. Epub 2011 Jun 21.

PMID:
21692604
28.

The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.

Peachman KK, Wieczorek L, Matyas GR, Polonis VR, Alving CR, Rao M.

Viral Immunol. 2010 Dec;23(6):627-32. doi: 10.1089/vim.2010.0061.

PMID:
21142448
29.

Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.

Brown BK, Cox J, Gillis A, VanCott TC, Marovich M, Milazzo M, Antonille TS, Wieczorek L, McKee KT Jr, Metcalfe K, Mallory RM, Birx D, Polonis VR, Robb ML.

PLoS One. 2010 Nov 5;5(11):e13849. doi: 10.1371/journal.pone.0013849.

30.

Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines.

Matyas GR, Wieczorek L, Bansal D, Chenine AL, Sanders-Buell E, Tovanabutra S, Kim JH, Polonis V, Alving CR.

Biochem Biophys Res Commun. 2010 Nov 26;402(4):808-12. doi: 10.1016/j.bbrc.2010.10.124. Epub 2010 Oct 30.

PMID:
21040700
31.

Temporal and regional regulation of gene expression by calcium-stimulated adenylyl cyclase activity during fear memory.

Wieczorek L, Maas JW Jr, Muglia LM, Vogt SK, Muglia LJ.

PLoS One. 2010 Oct 14;5(10):e13385. doi: 10.1371/journal.pone.0013385.

32.

The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.

Peachman KK, Wieczorek L, Polonis VR, Alving CR, Rao M.

Virology. 2010 Dec 20;408(2):213-23. doi: 10.1016/j.virol.2010.09.029. Epub 2010 Oct 20.

33.

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL.

Virology. 2010 Dec 5;408(1):80-8. doi: 10.1016/j.virol.2010.09.004. Epub 2010 Sep 28.

34.

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, Montefiori DC, Kappes JC, Ochsenbauer C.

Virology. 2010 Dec 5;408(1):1-13. doi: 10.1016/j.virol.2010.08.028. Epub 2010 Sep 21.

35.

[Care in the very first moments in the event of traumatic loss].

Cholin N, Wieczorek L, Romano H, Bernard-Brunel L, Dupuy C, Pétri S, Baubet T.

Soins Psychiatr. 2010 Jul-Aug;(269):24-8. French.

PMID:
20684469
36.

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Béné MC, De Vos J, Hernández JM, Hofmann WK, Mills KI, Gilkes A, Chiaretti S, Shurtleff SA, Kipps TJ, Rassenti LZ, Yeoh AE, Papenhausen PR, Liu WM, Williams PM, Foà R.

J Clin Oncol. 2010 May 20;28(15):2529-37. doi: 10.1200/JCO.2009.23.4732. Epub 2010 Apr 20.

37.

Gold nanoparticle chemiresistor sensor array that differentiates between hydrocarbon fuels dissolved in artificial seawater.

Cooper JS, Raguse B, Chow E, Hubble L, Müller KH, Wieczorek L.

Anal Chem. 2010 May 1;82(9):3788-95. doi: 10.1021/ac1001788.

PMID:
20384365
38.

Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.

Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS.

MAbs. 2010 May-Jun;2(3):266-74. Epub 2010 May 5.

39.

Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice.

Kolber BJ, Boyle MP, Wieczorek L, Kelley CL, Onwuzurike CC, Nettles SA, Vogt SK, Muglia LJ.

J Neurosci. 2010 Feb 17;30(7):2571-81. doi: 10.1523/JNEUROSCI.4470-09.2010.

40.

Human erythrocytes selectively bind and enrich infectious HIV-1 virions.

Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, Polonis VR, Rao M, Alving CR.

PLoS One. 2009 Dec 14;4(12):e8297. doi: 10.1371/journal.pone.0008297.

41.

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.

Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR.

AIDS. 2009 Oct 23;23(16):2069-77. doi: 10.1097/QAD.0b013e32832faea5.

PMID:
19710597
42.

Chronic 17beta-estradiol or cholesterol prevents stress-induced hippocampal CA3 dendritic retraction in ovariectomized female rats: possible correspondence between CA1 spine properties and spatial acquisition.

McLaughlin KJ, Wilson JO, Harman J, Wright RL, Wieczorek L, Gomez J, Korol DL, Conrad CD.

Hippocampus. 2010 Jun;20(6):768-86. doi: 10.1002/hipo.20678.

43.

Effects of stress, corticosterone, and epinephrine administration on learning in place and response tasks.

Sadowski RN, Jackson GR, Wieczorek L, Gold PE.

Behav Brain Res. 2009 Dec 14;205(1):19-25. doi: 10.1016/j.bbr.2009.06.027. Epub 2009 Jun 23.

44.

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome.

Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, Li R, Wei W, Bowen DT, Loeffler H, Hernandez JM, Hofmann WK, Haferlach T.

Blood. 2009 Jul 30;114(5):1063-72. doi: 10.1182/blood-2008-10-187203. Epub 2009 May 14.

45.

Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.

Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA.

Virol J. 2009 May 14;6:57. doi: 10.1186/1743-422X-6-57.

46.

Inkjet-printed gold nanoparticle chemiresistors: influence of film morphology and ionic strength on the detection of organics dissolved in aqueous solution.

Chow E, Herrmann J, Barton CS, Raguse B, Wieczorek L.

Anal Chim Acta. 2009 Jan 19;632(1):135-42. doi: 10.1016/j.aca.2008.10.070. Epub 2008 Nov 5.

PMID:
19100893
47.

Mie and Bragg plasmons in subwavelength silver semi-shells.

Maaroof AI, Cortie MB, Harris N, Wieczorek L.

Small. 2008 Dec;4(12):2292-9. doi: 10.1002/smll.200800203.

PMID:
19016499
48.

Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study.

Kohlmann A, Haschke-Becher E, Wimmer B, Huber-Wechselberger A, Meyer-Monard S, Huxol H, Siegler U, Rossier M, Matthes T, Rebsamen M, Chiappe A, Diemand A, Rauhut S, Johnson A, Liu WM, Williams PM, Wieczorek L, Haferlach T.

Clin Chem. 2008 Oct;54(10):1705-15. doi: 10.1373/clinchem.2008.108506. Epub 2008 Aug 21.

49.
50.

An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.

Kohlmann A, Kipps TJ, Rassenti LZ, Downing JR, Shurtleff SA, Mills KI, Gilkes AF, Hofmann WK, Basso G, Dell'orto MC, Foà R, Chiaretti S, De Vos J, Rauhut S, Papenhausen PR, Hernández JM, Lumbreras E, Yeoh AE, Koay ES, Li R, Liu WM, Williams PM, Wieczorek L, Haferlach T.

Br J Haematol. 2008 Sep;142(5):802-7. doi: 10.1111/j.1365-2141.2008.07261.x.

Supplemental Content

Loading ...
Support Center